Premium Industrial News

Europe Clears Extra COVID-19 Manufacturing Sites to Boost Supplies

Europe Clears Extra COVID-19 Manufacturing Sites to Boost Supplies

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 811 Words

GALWAY, IRELAND--April 5, 2021--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Europe has fast-tracked new manufacturing capacity for the leading approved COVID-19 vaccines in order to overcome a bottleneck in supplies in recent months.

Within this article: Details new manufacturing locations for vaccines, EU supply issues, main suppliers, existing contracts

Companies featured: Pfizer Incorporated (NYSE:PFE), BioNTech SE (NASDAQ:BNTX), Moderna (NASDAQ:MRNA)

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now!(All Fields Required)

Subscription Type:

  • Pay-Per-Article - $5.95
  • Annual Premium News Subscription - $365.00
Pricing Help?